Thought Leadership
Interpreters Support Novartis Patient Engagement Team
TransPerfect interpreters and translation services support patient interviews to increase awareness of IRDs. ...
Enabling Diversity & Inclusion in Clinical Trials: A CRO & IRB Perspective
Diversity in clinical research is imperative to ensure the safety and effectiveness of drugs and medical devices for all people—and everyone in the industry is a key stakeholder. Clinical trials today still lack ethnic diversity, and to make trials more inclusive and improve...
How to Increase Your Likelihood of Scientific Publication
Writing a scientific manuscript involves considerable planning and organization to boost your chances of publication in a peer-reviewed journal. Here, we show you how to develop a thorough plan to present research logically and how to avoid the common pitfalls of authorship, so...
UMotif - Empowering Patients to Drive Engagement and Adherence
Watch this presentation on how empowering patients with cloud solutions increases engagement. ...
TransPerfect’s GlobalLink Helps Top-10 Pharma Meet their EC Deadlines in More than 20 Countries
A top 10 pharma company was facing delays in EC submission deadlines for their global studies....
Lessons Learned in the Rush for a Vaccine and the Effects on Language Translation: Creating and Adapting Technologies
The rush to a vaccine has accelerated an already dynamic research process. This has led to many innovations and an evolution of procedures. The language translation industry has seen enormous stressors and has had to create and modify processes and technologies similarly. The...
ISPOR Europe 2020 Virtual Poster - Usability Testing for eCOAs
In order to ensure a fluid experience for a patient, usability testing is a critical data point to consider. Addressing both a patient’s needs and access to a digital platform is key to data collection. TransPerfect, along with our partners from Parexel, Clinical Ink, and...
Medical Annotation: Using Natural Language Processing for Adverse Events
TransPerfect's DataForce Streamlines Adverse Event Detection with NLP. ...
The Paper Chase - Clinical Outcome Assessments in the Digital Age
Patients are, at last, gaining a voice in healthcare. Stakeholders have come to recognize that patients have valuable information to share about their experiences with diseases and medications that should influence policy and treatment decisions. The U.S. Food & Drug...
Content Solutions for MDR & IVDR Readiness
The implementation dates for MDR (May, 2021) and IVDR (May, 2022) are fast approaching and non-compliant manufacturers are putting their EU market access at risk. These new regulatory requirements have created a “tsunami” of increased content requirements—especially in critical...
Artificial Intelligence in Life Sciences: Latest Developments Presented by Industry Leaders
Join TransPerfect's discussion with industry-experts from Pfizer, Bayer, CodaMetrix, Biogen, BI, Novartis, and Syneos Health about how AI is accelerating changes in the life sciences industry and ways they are leveraging data to support their teams, studies, and products. ...
Swimming in a Data Lake of eCOA Wearables
We all know there is a significant increase in data collected from wearable sensors, but what does that mean for eCOA? In our latest whitepaper , Mark Wade, Global Practice Leader for TransPerfect Life Sciences examines the considerations of adopting these sensors as an addition...
Wearables for eCOA: Practical Considerations for Improving Patient Data Capture
This electronic clinical outcome assessment (eCOA) webinar will explore the latest advancements in wearable technology and their potential to improve patient data collection in clinical studies. While there may still be ongoing discussions around deployment and standardization,...
Part 4: Clinical Trials and COVID-19: Remote Investigator Meetings
The novel COVID-19 virus has forced a lot of rapid changes in a very short period. Personally and professionally, we are all learning how to adapt. While restrictions on our day-to-day lives impact where, why, and how we interact, we still can come together as a community to...